DSS, INC. sold IBO
December 2, 2024 · Form 4 insider transaction
DSS, INC. sold 20 shares of Impact BioMedical Inc. at $2.90 per share, a transaction worth $58.00. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 112 days after the transaction.
Direction
Disposed (sell-side)
Shares
20
Price
$2.90
Total value
$58.00
InsiderDSS, INC.
Role—
CompanyImpact BioMedical Inc. (IBO)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 2, 2024
Filing dateMarch 24, 2025
Shares owned after53,080
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc.